- Home
- VNDA vs BYM Comparison
VNDA vs BYM Comparison
Compare VNDA & BYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- BYM
- Stock Information
- Founded
- VNDA 2002
- BYM 2002
- Country
- VNDA United States
- BYM United States
- Employees
- VNDA N/A
- BYM N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- BYM Investment Managers
- Sector
- VNDA Health Care
- BYM Finance
- Exchange
- VNDA Nasdaq
- BYM Nasdaq
- Market Cap
- VNDA 237.9M
- BYM 270.7M
- IPO Year
- VNDA 2006
- BYM N/A
- Fundamental
- Price
- VNDA $4.34
- BYM $10.48
- Analyst Decision
- VNDA Strong Buy
- BYM
- Analyst Count
- VNDA 3
- BYM 0
- Target Price
- VNDA $15.33
- BYM N/A
- AVG Volume (30 Days)
- VNDA 519.0K
- BYM 60.2K
- Earning Date
- VNDA 05-07-2025
- BYM 01-01-0001
- Dividend Yield
- VNDA N/A
- BYM 4.49%
- EPS Growth
- VNDA N/A
- BYM N/A
- EPS
- VNDA N/A
- BYM N/A
- Revenue
- VNDA $201,351,000.00
- BYM N/A
- Revenue This Year
- VNDA $16.86
- BYM N/A
- Revenue Next Year
- VNDA $39.78
- BYM N/A
- P/E Ratio
- VNDA N/A
- BYM N/A
- Revenue Growth
- VNDA 13.37
- BYM N/A
- 52 Week Low
- VNDA $3.81
- BYM $9.30
- 52 Week High
- VNDA $6.75
- BYM $11.77
- Technical
- Relative Strength Index (RSI)
- VNDA 51.79
- BYM 47.79
- Support Level
- VNDA $4.17
- BYM $10.32
- Resistance Level
- VNDA $4.41
- BYM $10.50
- Average True Range (ATR)
- VNDA 0.16
- BYM 0.10
- MACD
- VNDA 0.03
- BYM -0.00
- Stochastic Oscillator
- VNDA 73.61
- BYM 45.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About BYM Blackrock Municipal Income Quality Trust of Beneficial Interest
Blackrock Municipal Income Quality Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from U.S. federal income taxes, including the alternative minimum tax. The trust invests in various sectors such as transportation, utilities, health, education, corporate, housing, and others.